IPP Bureau
Aurobindo arm CuraTeQ receives Health Canada approval for bevacizumab biosimilar Bevqolva
By IPP Bureau - May 04, 2026
Notice of Compliance from Health Canada enables marketing authorisation for cancer biosimilar in Canadian market
Gufic Biosciences deepens global oncology push with fresh investment in Australia’s Selvax
By IPP Bureau - May 04, 2026
Selvax, founded in 1987, is focused on developing novel immunotherapy solutions with applications in both human and veterinary oncology
Moderna posts Q1 2026 loss despite revenue surge
By IPP Bureau - May 04, 2026
Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets
KIMS Hospitals launches Advanced Neurosciences Institute in Bengaluru
By IPP Bureau - May 04, 2026
The newly established institute is equipped with advanced infrastructure designed to integrate multiple specialties under one roof
OneSource Specialty Pharma's partners get Health Canada approval for generic Semaglutide injection
By IPP Bureau - May 04, 2026
Approval for generic Ozempic® in Canada strengthens OneSource’s global CDMO footprint in complex peptide injectable manufacturing
Health ministry releases new healthcare safety guidelines
By IPP Bureau - May 04, 2026
Week-long Fire Safety Week 2026 campaign focuses on strengthening fire prevention, preparedness, audits, and emergency response across hospitals and healthcare facilities
Kapil Dev inaugurates Digital PET-CT and Nuclear Medicine Department at Mahajan Imaging & Labs
By IPP Bureau - May 04, 2026
New facility at Pusa Road expands advanced diagnostic, theranostics, and treatment-planning capabilities across oncology, cardiology, neurology, and nephrology
HealthFab raises Rs 20 crore in Series A funding from Atomic Capital
By IPP Bureau - May 04, 2026
Funds to support product expansion, quick commerce growth, and manufacturing scale-up for holistic period care solutions
Sankara Eye Hospital hosts ‘CSSD 360’ workshop on sterilisation and patient safety
By IPP Bureau - May 04, 2026
Workshop focused on strengthening sterile processing standards, infection prevention, and CSSD best practices in healthcare settings
ten23 health successfully tests West Synchrony S1 PFS system on fill-finish lines
By IPP Bureau - May 04, 2026
Early implementation of West Synchrony S1 platform aims to accelerate biologics and vaccine development while reducing manufacturing risk for biopharma partners
HOSMAC enables first phase of 1,200-bed Tapanbhai Patel Memorial Hospital in Shirpur
By IPP Bureau - May 04, 2026
Hospital project inaugurated by Devendra Fadnavis aims to strengthen healthcare access across North Maharashtra and nearby regions
Wockhardt reports FY26 net profit of Rs 317 crore, Board approves fundraising plan
By IPP Bureau - May 04, 2026
Compared to a net loss of Rs 12 crore in FY25, the pharma major reported a consolidated turnaround in its financial performance
FDA advisory panel backs AstraZeneca prostate cancer combo in decisive vote
By IPP Bureau - May 04, 2026
The Committee backed the combination based on results from the CAPItello-281 Phase III trial, marking a key milestone in the regulatory pathway for AstraZeneca’s targeted therapy strategy in prostate cancer
Allergan Aesthetics ties referrals to skin cancer awareness month with $100,000 donation drive
By IPP Bureau - May 04, 2026
The initiative pairs consumer engagement with a public health message about prevention and early detection
Bristol Myers Squibb begins 2026 with growth momentum
By IPP Bureau - May 04, 2026
The company’s Growth Portfolio delivered $6.2 billion in revenue
